Vasista Vittal
SEC CIK 1652827 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGNX | REGENXBIO Inc. | CFO | 246.5K | — | $913.7K | 13 | 2021-07-27 | 2024-03-19 |
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
Vasista Vittal made no open-market trades at RGNX in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-21 | 2024-03-19 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | M - OptEx | $3.76 | +20.0K | 246.5K | +9% | +$75.4K |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | F - Tax | $17.95 | -4,534 | 210.5K | -2% | -$81.4K |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | A - Grant | $0.00 | +16.0K | 226.5K | +8% | $0 |
| D | 2023-06-02 | 2023-05-31 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | M - OptEx | $0.85 | +35.0K | 215.0K | +19% | +$29.8K |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | A - Grant | $0.00 | +46.2K | 180.0K | +35% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | F - Tax | $22.68 | -1,333 | 133.8K | -1.0% | -$30.2K |
| 2022-08-31 | 2022-08-30 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | S - Sale | $30.24 | -2,400 | 135.2K | -2% | -$72.6K | |
| M | 2022-08-08 | 2022-08-04+ | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | S - Sale | $35.19 | -17.7K | 154.8K | -10% | -$622.1K |
| 2022-08-03 | 2022-08-01 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | S - Sale | $31.26 | -2,400 | 155.2K | -2% | -$75.0K | |
| M | 2022-07-15 | 2022-07-13+ | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | S - Sale | $30.01 | -4,800 | 157.6K | -3% | -$144.0K |
| D | 2022-01-24 | 2022-01-20 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | M - OptEx | $0.85 | +29.9K | 162.4K | +23% | +$25.4K |
| D | 2022-01-04 | 2022-01-03 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | A - Grant | $0.00 | +8,900 | 132.5K | +7% | $0 |
| D | 2021-07-29 | 2021-07-27 | RGNX | REGENXBIO Inc. | Vasista Vittal | CFO | M - OptEx | $0.85 | +10.0K | 123.6K | +9% | +$8,500 |
Purchase Sale Sale after option exercise All abbreviations